Positive topline results were announced from the phase 2 LADDER study evaluating the efficacy and safety of its investigational Port Delivery System (PDS) with reçeteli özel ilaç in people with wet age-related macular degeneration (AMD).
In the study, it was reported that a majority of patients were able to go 6 months or longer between their initial implant and their first refill of the device, and in the highest dose of the study, 80% of patients went 6 months or longer.
30 August 2018
